Related by context. Frequent words. (Click for all words.) 78 DSMB 66 unblinded 64 phase IIb 64 Phase 2b study 61 Phase III clinical 61 Phase 2a trial 61 vandetanib 60 Phase IIb clinical 60 Phase Ib 60 multiple ascending dose 60 Phase 1b 59 Phase IIb trial 59 darusentan 59 Phase IIa trial 59 Phase IIa clinical 58 Phase III pivotal 58 pegloticase 58 dose escalation 58 confirmatory Phase 3 58 daclizumab 58 Entereg 58 clinical trial 58 Phase 2b clinical 58 phase 2a 58 Phase 2a 58 NDA submission 57 dose escalation trial 57 Phase III clinical trials 57 Phase 2a clinical 57 Zerenex 57 Phase 1b clinical 56 pivotal Phase III 56 abatacept 56 denufosol 56 Phase 2b trial 56 FavId 56 Phase IIb 56 HGS ETR1 56 IMGN# 56 efficacy endpoints 56 placebo controlled trials 56 BAY #-# 56 CoFactor 56 randomized Phase 56 vicriviroc 55 temsirolimus 55 FOLOTYN 55 GVAX 55 tolerated dose MTD 55 Clolar 55 PXD# 55 Phase III trials 55 single ascending dose 55 Biologics License Application BLA 55 multicenter randomized double 55 pralatrexate 54 pivotal Phase 54 IDX# 54 talactoferrin 54 investigational compounds 54 dose escalation study 54 pirfenidone 54 RG# [001] 54 Torisel 54 LymphoStat B 54 ridaforolimus 54 Qnexa 54 Nplate 54 velaglucerase alfa 54 mcg kg 54 investigational compound 54 Horizant 54 ambrisentan 54 label dose escalation 54 cutaneous T cell 54 eltrombopag 54 sunitinib 54 INCB# [002] 53 dimebon 53 L MTP PE 53 ACTEMRA 53 ofatumumab 53 ONGLYZA 53 AZD# 53 Stimuvax 53 azacitidine 53 picoplatin 53 mipomersen 53 ATryn R 53 blind randomized placebo 53 bifeprunox 53 dronedarone 53 Phase IIa 53 clinical trials 53 non inferiority 53 Marqibo 53 Biologics License Application 53 ASA# 53 investigational oral 53 primary endpoint 52 TORISEL